missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PLA2G4D (aa 188-265) Control Fragment Recombinant Protein
missing translation for 'orderingAttributeHoverText'
Quantity:
100 μL
missing translation for 'unitSize'
100µL
Beschreibung
Highest antigen sequence indentity to the following orthologs: Mouse (55%), Rat (55%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-145068 (PA5-145068. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The phospholipase A2 enzyme family, including PLA2G4D, catalyze the hydrolysis of glycerophospholipids at the sn-2 position and then liberate free fatty acids and lysophospholipids.[supplied by OMIM, Jun 2009].
Spezifikation
Spezifikation
| Accession Number | Q86XP0 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 283748 |
| Name | Human PLA2G4D (aa 188-265) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2610311B01Rik; cPLA2delta; cPLA2-delta; cytosolic phospholipase A2 delta; phospholipase A2 delta, cytosolic; phospholipase A2 group IVD; phospholipase A2, group IVD; phospholipase A2, group IVD (cytosolic); Pla2delta; PLA2G4D |
| Common Name | PLA2G4D |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur